Top Markets
Coin of the day
Regulus Therapeutics Inc. Regulus Therapeutics Inc.

Regulus Therapeutics Inc.

RGLS
Rangering i aksjer #17592
Regulus Therapeutics Inc., a biopharmaceutical firm in its clinical development... Regulus Therapeutics Inc., a biopharmaceutical firm in its clinical development phase, is dedicated to uncovering and advancing novel medications. Based in San Diego, California, the company's core focus is on modulating microRNAs to combat a variety of diseases across the United States. Its current pipeline highlights RG-012, an anti-miR compound engineered to inhibit miR-21, which is currently in a Phase II clinical study for Alport syndrome, a severe renal condition. Another significant candidate, RGLS8429, an anti-miR agent targeting miR-17, is being evaluated in a Phase 1b clinical trial for autosomal dominant polycystic kidney disease. Beyond these clinical programs, Regulus is also cultivating an extensive preclinical portfolio, emphasizing drug candidates with precise, organ-selective delivery strategies. The company was established in 2007.
Aksjekurs
$8.16
Sist synkronisert: 2025-06-26
Markedsverdi
$234.57M
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Regulus Therapeutics Inc. (RGLS)

Kategori

Historikk for aksjesplitt for Regulus Therapeutics Inc. (RGLS)
Aksjen Regulus Therapeutics Inc. (symbol: RGLS) har gjennomgått totalt 2 aksjesplitt.
Den nyeste splittelsen skjedde Jun 29, 2022.
Én RGLS-aksje kjøpt før Oct 04, 2018 tilsvarer i dag 0.0083333333333333 RGLS-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
2022-06-29 1:10 x0.1 x0.0083333333333333
2018-10-04 1:12 x0.083333333333333 x0.083333333333333
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH